Cancer is the second leading cause of death globally and increasing every year, including in Indonesia. Promethium-149 (149Pm) one beta-emitting (Eβ-max 1.07 MeV T1/2 2.21 days) radiolanthanides that can be used for therapeutic application. Radioisotope 149Pm produced with high specific activity was suitable labeling biomolecule as a targeted radiopharmaceutical cancer therapy. Radiochemical se...

introduction: differentiation between infection and sterile inflammation is one of the most difficult medical problems and is relevant in many clinical situations. scintigraphy with radiolabeled antibiotics, еspecially labeled fluoroquinolones, is a promising tool for diagnosing bacterial inflammation. we have attempted to synthesize 99mtc-norfloxacin and studied its properties in experiment. m...

introduction: the endemic occurrence of new strains of tuberculosis around the globe has initiated new research on developing diagnostic radiopharmaceutical based on antibiotics. methods:tc-99m labeled streptomycin was prepared using freshly milked 99mtco4- and various concentrations of streptomycin, stannous chloride at various temperatures in high yield radiochemical purity shown by hplc/rtlc...

The theranostic potential of Ac-based radiopharmaceuticals continues to increase as researchers seek innovative ways to harness the nuclear decay of this radioisotope for therapeutic and imaging applications. This communication describes the evaluation of Ac-DOTA-c(RGDyK) in both biodistribution and Cerenkov luminescence imaging (CLI) studies. Initially, La-DOTA-c(RGDyK) was prepared as a non-r...

BACKGROUND Phosphatidylserine (PS)-targeting positron emission tomography (PET) imaging with labeled small-molecule tracer is a crucial non-invasive molecule imaging method of apoptosis. In this study, semi-automatic radiosynthesis and biodistribution of N-(2-18F-fluoropropionyl)-bis(zinc(II)-dipicolylamine) (18F-FP-DPAZn2), as a potential small-molecule tracer for PET imaging of cell death in ...

The theranostic potential of (225)Ac-based radiopharmaceuticals continues to increase as researchers seek innovative ways to harness the nuclear decay of this radioisotope for therapeutic and imaging applications. This communication describes the evaluation of (225)Ac-DOTA-c(RGDyK) in both biodistribution and Cerenkov luminescence imaging (CLI) studies. Initially, La-DOTA-c(RGDyK) was prepared ...

Abstract Background The stability of precursors and reagents is utmost importance for developing a robust radiolabelling method that provides high constant radiochemical yield purity. While performing the QC [ 68 Ga]Ga-PSMA-11 injectable solutions according to Ph. Eur. Monograph has recently been published, trend instability standard PSMA-11, same used as precursor radiosynthesis, observed. Thi...

INTRODUCTION [(18)F]BAY94-9172 (Florbetaben) (Compound 8) is a positron emission tomography (PET) tracer that is currently in Phase III study for in vivo mapping of fibrillar amyloid β as a pathological hallmark for Alzheimer's disease. This work reports new methods for the synthesis of [(19)F]BAY94-9172 and its two different precursors and radiosynthesis of [(18)F]BAY94-9172 with the two precu...

Introduction Bacterial infection is one of the major causes of morbidity and mortality especially in developing countries. Nuclear medicine has an important role in helping the diagnosis of deep-seated infections by developing more specific radiopharmaceuticals. The aim of this study was to evaluate 99mTc-labeling ceftriaxone as a new radiopharmaceutical for Staphylococcus aureus infection imag...